The National Bleeding Disorders Foundation (NBDF) is excited to announce a new online, enduring, and accredited educational activity available to healthcare providers. The intended audience are hematologists, emergency medicine physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other members of the hemophilia care team in the United States
“Clinical Assessment of Gene Therapies for Hemophilia A and Hemophilia B: Key Takeaways for Your Practice,” was developed through a strategic collaboration between Medscape and NBDF. It is intended for learners to enhance their ability to recognize the key differences in gene therapies for hemophilia A compared with hemophilia B, and to leverage evolving data about gene therapies for hemophilia to better care for patients.
Participants who complete this activity will:
Have increased knowledge regarding the
- Clinical and practical evidence surrounding gene therapies for hemophilia
- Differences in gene therapies for hemophilia A and hemophilia B
Have greater competence related to
- Identifying eligible and suitable candidates for gene therapies for hemophilia
- Monitoring patients with hemophilia who receive gene therapies
Demonstrate greater confidence in their ability to
- Counsel patients and colleagues about gene therapies for hemophilia
Faculty
Steven W. Pipe, MD
Professor of Pediatrics and Pathology
Pediatric Medical Director
Hemophilia and Coagulation Disorders Program
Director, Special Coagulation Laboratory
University of Michigan
Ann Arbor, Michigan
Amy L. Dunn, MD
Professor of Pediatrics
Director of Pediatric Hematology
Hemophilia Treatment Center
Nationwide Children’s Hospital
The Ohio State University College of Medicine
Columbus, Ohio
Doris V. Quon, MD, PhD
Hemophilia Treatment Center
Nationwide Children’s Hospital
The Ohio State University College of Medicine
Columbus, Ohio
Please note that there are no fees for participating in or receiving credit for this online educational activity. To learn more about available credits and to register visit the program homepage.
This program is supported by an independent educational grant from CSL Behring.
